Stockreport

Precision Therapeutics Bolsters Scientific Advisory Board with the Appointment of Dr. Paul Kornblith

PRECISION THERAPEUTICS INC COMMON  (AIPT) 
US:NASDAQ Investor Relations: investors.skylinemedical.com/investor-relations
PDF MINNEAPOLIS, Sept. 13, 2018 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (NASDAQ: AIPT) (“Precision” or “the Company”), a company focused on applying artificial int [Read more]